Postoperative permanent pacemaker implantation in patients undergoing trans-catheter aortic valve implantation: What is the incidence and are there any predicting factors?

Interactive Cardiovascular and Thoracic Surgery

Volumn 12, Issue 2, 2011, Pages 243-253

  Bates, Matthew G D ^a   Matthews, Iain G ^b   Fazal, Iftikhar A ^b   Turley, Andrew J ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Atrioventricular block; Calcific aortic stenosis; Evidence based medicine; Permanent pacemaker implantation; Postoperative complications; Trans catheter aortic valve implantation

Indexed keywords

AORTA VALVE PROSTHESIS; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; EVIDENCE BASED MEDICINE; HEART LEFT BUNDLE BRANCH BLOCK; HEART MUSCLE CONDUCTION DISTURBANCE; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MINIMALLY INVASIVE CARDIAC SURGERY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; SURGICAL APPROACH; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AORTIC VALVE STENOSIS; CARDIAC PACING, ARTIFICIAL; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PACEMAKER, ARTIFICIAL; POSTOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79551595802     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.256578     Document Type: Article

References (24)

1. Dunning J, Prendergast B, Mackway-Jones K. Towards evidence-basedmedicine in cardiothoracic surgery: best BETS. Interact Cardio Vasc Thorac Surg 2003;2:405-409.
2. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, Derumeaux G, Anselme F, Laborde F, Leon MB. Percutaneous transcatheterimplantation of an aortic valve prosthesis for calcific aorticstenosis: first human case description. Circulation 2002;106:3006-3008.
3. Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P, Cheung A, Ye J, Kerr C, Lichtenstein SV, Webb JG. Atrioventricularblock after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv 2008;1:305-309.
4. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, Ramondo A, Ussia G, Wenaweser P, Windecker S, Laborde J-C, de Jaegere P, Serruys PW. Procedural and 30-day outcomes following transcatheteraortic valve implantation using the third generation (18 Fr) corevalverevalving system: results from the multicentre, expanded evaluationregistry 1-year following CE mark approval. Euro Intervention 2008;4:242-249.
5. Piazza N, Onuma Y, Jesserun E, Kint PP, Maugenest A-M, Anderson RH, de Jaegere P, Serruys PW. Early and persistent intraventricular conductionabnormalities and requirements for pacemaking after percutaneousreplacement of the aortic valve. JACC Cardiovasc Interv 2008;1:310-316.
6. Jilaihawi H, Chin D, Vasa-Nicotera M, Jeilan M, Spyt T, Ng GA, Bence J, Logtens E, Kovac J. Predictors for permanent pacemaker requirement after transcatheter aortic valve implantation with the Core Valve bioprosthesis. Am Heart J 2009;157:860-866.
7. Calvi V, Puzzangara E, Pruiti GP, Conti S, Di Grazia A, Ussia GP, Capodanno D, Tamburino C. Early conduction disorders following percutaneous aortic valve replacement. Pacing Clin Electrophysiol 2009;32:S126-S130.
8. Webb J, Altwegg L, Boone R, Cheung A, Ye J, Lichtenstein S, Lee M, Masson JB, Thompson C, Moss R, Carere R, Munt B, Nietlispach F, Humphries K. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009;119:3009-3016.
9. Gutierrez M, Rodes-Cabau J, Bagur R, Doyle D, De Larochelliere R, Bergeron S, Lemieux J, Villeneuve J, Cote M, Bertrand OF, Porier P, Clavel M-A, Pibarot P, Dumont E. Electrocardiographic changes and clinical outcomes after transapical aortic valve implantation. Am Heart J 2009;158:302-308.
10. Ye J, Cheung A, Lichtenstein S, Nietlispach F, Albugami S, Masson J-B, Thompson CR, Munt B, Moss R, Carere RG, Jamieson WR, Webb JG. Transapical transcatheter aortic valve implantation: follow-up to 3 years. J Thorac Cardiovasc Surg 2010;139:1107-1113.
11. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, Osten M, Natarajan MK, Velianou JL, Martucci G, De Varennes B, Chisholm R, Peterson MD, Lichtenstein SV, Nietlispach F, Doyle D, De Larochelliere R, Teoh K, Chu V, Dancea A, Lachapelle K, Cheema A, Latter D, Horlick E. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-1090.
12. Baan J Jr, Yong ZY, Koch KT, Henriques JPS, Bouma BJ, Vis MM, Cocchierei R, Piek JJ, de Mol BAJM. Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the Core Valve prosthesis. Am Heart J 2010;159:497-503.
13. Guinot PG, Depoix JP, Etchegoyen L, Benbara A, Provenchere S, Dilly MP, Philip I, Enguerand D, Ibrahim H, Vahanian A, Himbert D, Al-Attar N, Nataf P, Desmonts J-M, Montravers P, Longrois D. Anesthesia and perioperative management of patients undergoing transcatheter aortic valve implantation: analysis of 90 consecutive patients with focus on perioperative complications. J Cardiothorac Vasc Anesth 2010;24:752-761.
14. Erkapic D, Kim WK, Weber M, Mollmann H, Berkowitsch A, Zaltsberg S, Pajitnev DJ, Rixe J, Neumann T, Kuniss M, Sperzel J, Hamm CW, Pitschner HF. Electrocardiographic and further predictors for permanentpacemaker requirement after transcatheter aortic valve implantation. Europace 2010;12:1188-1190.
15. Walther T, Schuler G, Borger M, Kempfert J, Seeburger J, Ruckert Y, Ender J, Linke A, Scholz M, Falk V, Mohr FW. Transapical aortic valveimplantation in 100 consecutive patients: comparison to propensitymatchedconventional aortic valve replacement. Eur Heart J 2010;31:1398-1403.
16. Bleiziffer S, Ruge H, Horer J, Hutter A, Geisbusch S, Brockmann G, Mazzitelli D, Bauernschmitt R, Lange R. Predictors for new-onsetcomplete heart block after transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010;3:524-530.
17. Totaro P, Calamai G, Montesi G, Barzaghi C, Vaccari M. Continuoussuture technique and impairment of the atrioventricular conductionafter aortic valve replacement. J Card Surg 2000;15:418-423.
18. Limongelli G, Ducceschi V, D'Andrea A, Renuzulli A, Sarubbi B, De Feo M, Cerasuolo F, Calabro R, Cotrufo M. Risk factors for pacemakerimplantation following aortic valve replacement: a single centre experience. Heart 2003;89:901-904.
19. Elahi M, Usmaan K. The bioprosthesis type and size influence thepostoperative incidence of permanent pacemaker implantation inpatients undergoing aortic valve surgery. J Interv Card Electrophysiol2006;15:113-118.
20. Erdogan H, Kayalar N, Ardal H, Omeroglu S, Kirali K, Guler M, Akinci E, Yakut C. Risk factors for requirement of permanent pacemaker implantationafter aortic valve replacement. J Card Surg 2006;21:211-215.
21. Dawkins S, Hobson A, Kalra P, Tang A, Monro J, Dawkins K. Permanentpacemaker implantation after isolated aortic valve replacement: incidence, indications and predictors. Ann Thor Surg 2008;85:108-112.
22. Nardi P, Pellegrino A, Scafuri A, Bellos K, De Propris S, Polisca P, Chiariello L. Permanent pacemaker implantation after isolated aorticvalve replacement: incidence, risk factors and surgical technicalaspects. J Cardiovasc Med 2010;11:14-19.
23. Huynh H, Dalloul G, Ghanbari H, Burke P, David M, Daccarett M, Machado C, David S. Permanent pacemaker implantation followingaortic valve replacement: current prevalence and clinical predictors. Pacing Clin Electrophysiol 2009;32:1520-1525.
24. El-Khally Z, Thibault B, Staniloae C, Theroux P, Dubuc M, Roy D, Guerra P, Macle L, Talajic M. Prognostic significance of newly acquired bundlebranch block after aortic valve replacement. Am J Cardiol 2004;94:1008-1011.